What Are Fibroids and Why Do They Grow?

Uterine fibroids (leiomyomas) are benign smooth muscle tumours of the uterus, affecting up to 70-80% of women by the time they reach menopause. While many fibroids are asymptomatic, a significant proportion cause heavy menstrual bleeding, pelvic pain, urinary frequency, and reproductive complications. Fibroids are oestrogen and progesterone-dependent: they grow during reproductive years when hormones are high and typically shrink after menopause when hormone levels decline.

The conventional approach to fibroids focuses on hormonal manipulation (GnRH agonists, selective progesterone receptor modulators) or surgical intervention (myomectomy, hysterectomy). What is consistently overlooked is the role of the gut in regulating the very hormones that drive fibroid growth.

The Estrobolome: Your Gut's Oestrogen Thermostat

The estrobolome refers to the aggregate of enteric bacterial genes whose products are capable of metabolising oestrogens. The key enzyme is beta-glucuronidase, produced by certain gut bacteria. Here is how the system works:

  • The liver conjugates oestrogen (attaches glucuronic acid) to deactivate it and prepare it for excretion through bile into the intestines
  • In a healthy gut, most conjugated oestrogen passes through the intestine and is eliminated in stool
  • However, gut bacteria that produce beta-glucuronidase can deconjugate oestrogen, removing the glucuronic acid tag and allowing active oestrogen to be reabsorbed into circulation through the enterohepatic cycle

When the estrobolome is dysbiotic and beta-glucuronidase activity is elevated, more oestrogen is recirculated rather than eliminated. This raises overall oestrogen exposure, potentially accelerating the growth of oestrogen-sensitive tissues including fibroids.

A dysbiotic estrobolome does not just affect total oestrogen levels. It affects the ratio of oestrogen metabolites, potentially increasing the proportion of proliferative 16-alpha-hydroxy oestrone relative to the protective 2-hydroxy oestrone. This metabolite ratio may be more relevant to fibroid growth than total oestrogen levels alone.

Evidence Connecting Gut Dysbiosis and Fibroids

While direct clinical trials are still emerging, multiple lines of evidence support the gut-fibroid connection:

  • Constipation and fibroids: chronic constipation reduces oestrogen excretion and is associated with higher circulating oestrogen levels. Epidemiological data show that women with regular constipation have a higher prevalence of fibroids
  • Obesity and the microbiome: obesity is a well-established risk factor for fibroids, partly because adipose tissue produces oestrogen via aromatase. Obesity is also associated with gut dysbiosis, creating dual pathways for oestrogen excess
  • Antibiotic exposure: antibiotic use disrupts the gut microbiome, including the estrobolome. Some observational data suggest that frequent antibiotic use is associated with increased fibroid risk, though confounding factors make this relationship difficult to establish definitively
  • Dietary fibre and oestrogen: high-fibre diets are consistently associated with lower circulating oestrogen levels, partly through enhanced faecal excretion and reduced enterohepatic recirculation

Gut-Focused Strategies for Fibroid Management

Promote Healthy Oestrogen Elimination

  • High-fibre diet: aim for 30-35g daily from diverse plant sources. Fibre binds oestrogen in the intestine and promotes excretion
  • Regular bowel movements: at least one daily bowel movement is essential for oestrogen clearance. Address constipation proactively with magnesium, adequate hydration, and motility-supporting foods
  • Cruciferous vegetables daily: broccoli sprouts, broccoli, Brussels sprouts, and cauliflower provide DIM and I3C that shift oestrogen metabolism toward the protective 2-hydroxy pathway
  • Ground flaxseeds: 2 tablespoons daily. Lignans modulate oestrogen receptor activity and promote SHBG production, which binds free oestrogen

Reduce Beta-Glucuronidase Activity

  • Calcium-D-glucarate: this compound inhibits beta-glucuronidase, supporting proper oestrogen conjugation and elimination. Found naturally in cruciferous vegetables, oranges, and apples, it can also be supplemented at 1500-3000mg daily
  • Probiotic support: Lactobacillus species are associated with healthier estrobolome function and lower beta-glucuronidase activity
  • Reduce gut inflammation: inflammatory conditions in the gut favour the growth of beta-glucuronidase-producing bacteria

Anti-Inflammatory Dietary Foundation

  • Omega-3 fatty acids: anti-inflammatory and may inhibit fibroid cell proliferation
  • Green tea: EGCG has shown anti-proliferative effects on fibroid cells in preclinical studies, and a clinical trial demonstrated reduced fibroid volume with green tea extract supplementation
  • Vitamin D: deficiency is strongly associated with fibroid prevalence, and supplementation may inhibit fibroid growth. Vitamin D also supports gut barrier integrity
  • Limit alcohol: alcohol impairs hepatic oestrogen metabolism and increases intestinal permeability

The Integrated Approach

Managing fibroids through gut health is not about replacing medical treatment but about addressing a root-level driver that conventional treatment typically ignores. By supporting healthy oestrogen metabolism through the estrobolome, reducing systemic inflammation, and maintaining regular bowel function, you create an internal environment that is less hospitable to fibroid growth. GutIQ helps you evaluate the dietary and digestive factors that influence oestrogen metabolism and gut health, giving you a clear framework for gut-focused interventions that complement your medical management plan.